在XRN2-缺少癌细胞对多分子 (ADP-ribose) 聚合酶抑制敏感性的分子基础
Talysa Viera1, Quinn Abfalterer1, Alyssa Neal1
1Department of Chemistry, New Mexico Institute of Mining and Technology, Socorro, NM 87801, USA.
Cancers
|February 10, 2024
概括
在XRN2 (5-3-外核酶2) 缺乏导致R循环积累和DNA损伤. 将XRN2缺乏与PARP抑制剂结合起来,通过增强的DNA损伤和细胞死亡,在癌细胞中触发了合成致死性.
科学领域:
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
- 癌症研究 癌症研究
背景情况:
- R-循环 (RNA-DNA杂交) 是基因组不稳定性和DNA损伤的来源.
- 5'-3'-外核酶2 (XRN2) 缺乏会增加R循环和DNA损伤,原因是RNA聚合酶II终结受损.
- 缺少XRN2会导致增高的多基酸聚合酶1 (PARP1) 活性,以及与PARP1.1的合成致命相互作用.
研究的目的:
- 研究与PARP抑制剂治疗的XRN2缺乏癌细胞的合成致死性背后的分子机制.
- 确定由XRN2缺乏和PARP抑制联合激活的细胞应激反应途径.
主要方法:
- 利用了XRN2缺乏的肺癌和乳腺癌细胞系.
- 使用临床相关的PARP抑制剂 (Rucaparib,Olaparib).
- 评估了R环和DNA双链断裂形成,PARP1活性,复制应力和caspase-3激活.
主要成果:
- 缺乏XRN2的癌细胞对PARP抑制剂敏感.
- 结合XRN2缺乏和PARP抑制会加剧R环和DNA双链断裂的形成.
- 缺乏XRN2会过度激活PARP1,导致在PARP抑制时增加复制应激.
- 这种增强的应激反应激活了caspase-3,诱导癌细胞死亡.
结论:
- 通过放大与R循环相关的DNA损伤和复制压力,PARP抑制会在XRN2缺乏的癌细胞中触发合成致死性.
- 这些发现为这些细胞对PARP抑制剂的敏感性提供了机制性的见解.
- 这项研究支持利用PARP抑制剂向XRN2缺乏癌症的翻译潜力.
相关概念视频
Nucleotide Excision Repair
3.5K
DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
3.5K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
DNA Damage can Stall the Cell Cycle
9.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Long-patch Base Excision Repair
7.0K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.0K


